Literature DB >> 8985092

Human monoclonal antibodies specific for the tumour associated Thomsen-Friedenreich antigen.

K Dahlenborg1, L Hultman, R Carlsson, B Jansson.   

Abstract

Five hybridomas producing human monoclonal antibodies (MAbs) of IgA and IgM isotypes reacting with the tumour associated TF antigen were generated after in vitro immunisation or antigen specific isolation of normal peripheral blood B cells using asialoglycophorin, a TF containing antigen. All 5 antibodies produced by the hybridomas bound strongly to asialoglycophorin and to synthetic glycoprotein containing the TF-epitope, with preference to the beta form (Galb1-3GalNAc-beta-O-CETE-BSA) as compared to the alpha form (Galbl-3GalNAc-alpha-O-APE-HSA) in ELISA. Flow cytometry analysis revealed binding to carcinoma cell lines of different origin such as breast, colon, pancreas, ovary, bladder, lung and, in addition, to some tumour cell lines of haematopoietic origin. Immunohistochemical analysis of tumour tissues revealed staining patterns typical for mucins, and the antibodies were found to bind to glycoproteins among the MUC-1 positive high m.w. fraction shed from a TF antigen positive ovarian carcinoma cell line.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8985092     DOI: 10.1002/(sici)1097-0215(19970106)70:1<63::aid-ijc10>3.0.co;2-e

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  4 in total

1.  Signals sustaining human immunoglobulin V gene hypermutation in isolated germinal centre B cells.

Authors:  K Dahlenborg; J D Pound; J Gordon; C A Borrebaeck; R Carlsson
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

2.  Postoperative change of anti-Thomsen-Friedenreich and Tn IgG level: the follow-up study of gastrointestinal cancer patients.

Authors:  Eugeniy-P Smorodin; Oleg-A Kurtenkov; Boris-L Sergeyev; Kristel-E Kodar; Valentin-I Chuzmarov; Vladimir-P Afanasyev
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

3.  Preclinical Analysis of JAA-F11, a Specific Anti-Thomsen-Friedenreich Antibody via Immunohistochemistry and In Vivo Imaging.

Authors:  Loukia G Karacosta; John C Fisk; Joseph Jessee; Swetha Tati; Bradley Turner; Diala Ghazal; Rachel Ludwig; Holly Johnson; Julia Adams; Munawwar Sajjad; Steven Koury; Rene Roy; James R Olson; Kate Rittenhouse-Olson
Journal:  Transl Oncol       Date:  2018-02-22       Impact factor: 4.243

4.  Designer glycopeptides for cytotoxic T cell-based elimination of carcinomas.

Authors:  Yanfei Xu; Sandra J Gendler; Alessandra Franco
Journal:  J Exp Med       Date:  2004-03-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.